ID   AH130FN-TC
AC   CVCL_5683
SY   AH130FN; AH-130F(N); AH-130FN; AH-130 FN; AH 130 FN
DR   CLS; 500451
DR   TKG; TKG 0053
DR   TKG; TKG 0667
DR   Wikidata; Q54748769
RX   PubMed=710800;
RX   PubMed=14247586;
CC   Transformant: ChEBI; CHEBI:76329; 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4367 ! AH130
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
RX   PubMed=710800; DOI=10.20772/cancersci1959.74.2_240;
RA   Kohga S.;
RT   "Thromboplastic and fibrinolytic activities of ascites tumor cells of
RT   rats, with reference to their role in metastasis formation.";
RL   Gann 69:461-470(1978).
//
RX   PubMed=14247586; DOI=10.20772/cancersci1959.55.5_363;
RA   Hirono I., Kojima K., Kachi H., Ohashi A., Sasaoka I.;
RT   "Development of free-cell sublines of the ascites hepatoma AH-130 and
RT   their biological properties.";
RL   Gann 55:363-372(1964).
//